Review on clinical application of Saxagliptin and Metformin Extended-Release (XR)fix-dose combination tablet in type 2 diabetes
10.3969/j.issn.1006-6187.2017.01.021
- VernacularTitle:沙格列汀和二甲双胍缓释片治疗2型糖尿病的研究进展
- Author:
Juming LU
- Keywords:
Saxagliptin;
Metformin;
Combination;
Efficacy;
Safety
- From:
Chinese Journal of Diabetes
2017;25(1):91-94
- CountryChina
- Language:Chinese
-
Abstract:
[Summary] There is a complementary or synergistic action of saxagliptin and metformin when used in combination. Combination therapy with saxagliptin and metformin can effectively reduce blood glucose and body weight with a low risk of hypoglycemia in patients with diabetes. Additionally,the cardiovascular safety of saxagliptin has been confirmed by the SAVOR study,whereas a cardiovascular protective effect of metformin has been demonstrated by the UKPDS study. As being taken orally once daily,saxagliptin and metformin extended-release fix-dose combination tablet can further improve patients′compliance and adherence. According to the guidelines,this tablet could be recommended as the initial treatment for newlydiagnosed type 2 diabetes with HbA1 c higher than 7. 5%,or in those with inadequately glycemic control under metformin monotherapy.
